BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3810012)

  • 1. Impaired activation of the neutrophil oxidative metabolism in chronic inflammatory bowel disease.
    Verspaget HW; Elmgreen J; Weterman IT; Peña AS; Riis P; Lamers CB
    Scand J Gastroenterol; 1986 Nov; 21(9):1124-30. PubMed ID: 3810012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content.
    Verspaget HW; Peña AS; Weterman IT; Lamers CB
    Gut; 1988 Feb; 29(2):223-8. PubMed ID: 2831119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of exudative neutrophilic granulocytes in patients with Crohn's disease or ulcerative colitis.
    Wandall JH
    Scand J Gastroenterol; 1985 Nov; 20(9):1151-6. PubMed ID: 4089525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical analysis of enzymic markers of inflammation in rectal biopsies from patients with ulcerative colitis and Crohn's disease.
    O'Morain C; Smethurst P; Levi AJ; Peters TJ
    J Clin Pathol; 1983 Nov; 36(11):1312-6. PubMed ID: 6313772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced superoxide anion release of normal neutrophil granulocytes primed with sera of patients with inactive inflammatory bowel disease.
    Griga T; Tromm A; Schwegler U; May B
    Z Gastroenterol; 1995 Jul; 33(6):345-8. PubMed ID: 7668025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subnormal activation of phagocytes by complement in chronic inflammatory bowel disease? Neutrophil chemotaxis to complement split product C5a.
    Elmgreen J
    Gut; 1984 Jul; 25(7):737-42. PubMed ID: 6735255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial defect of neutrophil oxidative metabolism in Crohn's disease.
    Verspaget HW; Mieremet-Ooms MA; Weterman IT; Peña AS
    Gut; 1984 Aug; 25(8):849-53. PubMed ID: 6086464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut luminal neutrophil migration is influenced by the anatomical site of Crohn's disease.
    Arnott ID; Drummond HE; Ghosh S
    Eur J Gastroenterol Hepatol; 2001 Mar; 13(3):239-43. PubMed ID: 11293442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis.
    Rhodes JM; Potter BJ; Brown DJ; Jewell DP
    Gastroenterology; 1982 Jun; 82(6):1327-34. PubMed ID: 6978274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphonuclear leukocyte function in ulcerative colitis and Crohn's disease.
    Kirk AP; Cason J; Fordham JN; Brown KA; Goddard DH; Holborow EJ; Lennard-Jones JE
    Dig Dis Sci; 1983 Mar; 28(3):236-48. PubMed ID: 6825543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased neutrophil receptors for and response to the proinflammatory bacterial peptide formyl-methionyl-leucyl-phenylalanine in Crohn's disease.
    Anton PA; Targan SR; Shanahan F
    Gastroenterology; 1989 Jul; 97(1):20-8. PubMed ID: 2542118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminished cytochrome b content and toxic oxygen metabolite production in circulating neutrophils from patients with Crohn's disease.
    Solis-Herruzo JA; Fernandez B; Vilalta-Castell E; Muñoz-Yagüe MT; Hernandez-Muñoz I; de la Torre-Merino MP; Balsinde J
    Dig Dis Sci; 1993 Sep; 38(9):1631-7. PubMed ID: 8395381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme in Crohn's disease and ulcerative colitis.
    Silverstein E; Fierst SM; Simon MR; Weinstock JV; Friedland J
    Am J Clin Pathol; 1981 Feb; 75(2):175-8. PubMed ID: 6258421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis.
    Meyers S; Sacher DB; Taub RN; Janowitz HD
    Gut; 1976 Nov; 17(11):911-5. PubMed ID: 1087263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
    Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motility of neutrophils and monocytes in Crohn's disease and ulcerative colitis.
    Rhodes JM; Jewell DP
    Gut; 1983 Jan; 24(1):73-7. PubMed ID: 6848434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment.
    Oudkerk Pool M; Ellerbroek PM; Ridwan BU; Goldschmeding R; von Blomberg BM; Peña AS; Dolman KM; Bril H; Dekker W; Nauta JJ
    Gut; 1993 Jan; 34(1):46-50. PubMed ID: 8432451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil apoptosis is delayed in patients with inflammatory bowel disease.
    Brannigan AE; O'Connell PR; Hurley H; O'Neill A; Brady HR; Fitzpatrick JM; Watson RW
    Shock; 2000 May; 13(5):361-6. PubMed ID: 10807010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lysozyme in Crohn's disease and ulcerative colitis.
    Helman CA; Novis BH; Bank S; Wormold L; Jacobs P
    S Afr Med J; 1977 Dec; 52(26):1042-4. PubMed ID: 609977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation.
    Jenkins D; Seth R; Kummer JA; Scott BB; Hawkey CJ; Robins RA
    J Pathol; 2000 Feb; 190(2):184-9. PubMed ID: 10657017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.